Fiji Outbreak & DoxyPEP
Impossibile aggiungere al carrello
Rimozione dalla Lista desideri non riuscita.
Non è stato possibile aggiungere il titolo alla Libreria
Non è stato possibile seguire il Podcast
Esecuzione del comando Non seguire più non riuscita
Fiji Outbreak & DoxyPEP
-
Letto da:
-
Di:
This digest is brought to you by the podcast HIV: The Morning After.
Fiji’s first molecular surveillance of its fast-growing HIV outbreak found three large transmission clusters, with no needle and syringe programmes in place and progress far behind the global testing-and-treatment targets (standing at 40, 22 and 3 against a goal of 95, 95, 95), according to the International AIDS Society.
Real-world rollouts of the after-sex antibiotic doxyPEP brought large, sustained falls in syphilis and chlamydia but not gonorrhoea, while the 4CMenB vaccine showed no protective effect against gonorrhoea across three trials, according to the International AIDS Society.
A Bundibugyo Ebola outbreak in the Democratic Republic of the Congo — a major focus at the HIV conference — had reached 2,905 confirmed cases and 1,269 deaths by 22 July, a case fatality rate of 43.7%, with figures still evolving, according to the International AIDS Society.